IN BRIEF: Creo Medical buys base and nearby site for GBP4.3 million

Creo Medical Group PLC - Chepstow, Wales-based medical device company specialising in surgical ...

Alliance News 14 June, 2021 | 2:58PM
Email Form Facebook Twitter LinkedIn RSS

Creo Medical Group PLC - Chepstow, Wales-based medical device company specialising in surgical endoscopy - Buys freehold interest in headquarters and an adjoining site in Chepstow for GBP4.3 million. Expects purchase from the original developer, Fastnet Property Investments Limited, to be completed by early July.

Creo House headquarters has an 18,000 square foot capacity, with the neighbouring site adding a further 16,000 square feet. Notes that this larger space will allow Creo Medical to expand its commercial operations and logistical reach further across Europe.

Say its scope has already been expanded by the acquisition of Navarra, Spain-based Albyn Medical SL in July for EUR25 million and Belgian-based medical devices firm Boucart Medical for EUR4.5 million in November 2020. Additional space will increase manufacturing capacity for several devices due for commercial roll-out. These include the Creo GI gastro-intestinal suite of advanced energy devices, the complimentary Croma Advanced Energy Platform and Speedboat device for use in gastrointestinal therapeutic endoscopy.

Current stock price: 205.00 pence, down 0.5%

Year-to-date change: up 5.7%

By Scarlett Butler; scarlettbutler@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Creo Medical Group PLC 205.00 GBX 0.00 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement